DP
Dana Pizzuti (Chief Med and Dev Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Crinetics Pharmaceuticals, Inc. (CRNX). The largest single filing was $225K of CRNX (5,000 sh × $45.02, as filed), executed Dec 1 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$225K
shares × price, as filed
Last traded
Dec 1 2025
Filed Dec 3 2025
Median ADV $326.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
CRNXRecent filings
CRNXSALE
Crinetics Pharmaceuticals, Inc.
View filing →
$225K5,000 sh × $45.02
Exec Dec 1 2025
Filed Dec 3 2025 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $209K
4,900 sh × $42.65
Exec Nov 3 2025
Filed Nov 5 2025 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $209K
5,000 sh × $41.81
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $160K
5,000 sh × $32.10
Exec Sep 2 2025
Filed Sep 4 2025 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $913K
30,000 sh × $30.43
Exec Aug 22 2025
Filed Aug 26 2025 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $189K
6,492 sh × $29.18
Exec Aug 20 2025
Filed Aug 21 2025 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $195K
5,000 sh × $39.07
Exec Feb 3 2025
Filed Feb 5 2025 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $781K
15,000 sh × $52.09
Exec Jan 3 2025
Filed Jan 7 2025 · 5:30 PM ET